REQUEST A DEMO
Total
USD $0.00
Search more companies

Ardence Pharma Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Ardence Pharma Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Ardence Pharma Sdn. Bhd. is an enterprise based in Malaysia. Its main office is in Petaling Jaya. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Ardence Pharma Sdn. Bhd. was incorporated on August 16, 2018. In its most recent financial highlights, the company reported a net sales revenue increase of 133.13% in 2021. Over the same period, its total assets grew by 93.78%. In 2021, Ardence Pharma Sdn. Bhd.’s net profit margin increased by 3.81%.

Headquarters
108 Block E, Phileo Damansara 1, 9 Jalan 16/11, Off Jalan Damansara
Petaling Jaya; Selangor; Postal Code: 46350

Contact Details: Purchase the Ardence Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ardence Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Ardence Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
August 16, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
51.72%
Purchase this report to view the information.
39.66%
Purchase this report to view the information.
8.62%
Company Performance
Financial values in the chart are available after Ardence Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
133.13%
Total operating revenue
133.13%
Operating profit (EBIT)
170.08%
EBITDA
169.87%
Net Profit (Loss) for the Period
160.58%
Total assets
93.78%
Total equity
178.9%
Operating Profit Margin (ROS)
6.4%
Net Profit Margin
3.81%
Return on Equity (ROE)
-6.77%
Quick Ratio
2.5%
Cash Ratio
0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?